Unspecified feeding or eating disorder

From WikiMD's WELLNESSPEDIA

Unspecified Feeding or Eating Disorder (UFED) is a category of eating disorders that do not meet the full criteria for any of the specific disorders within the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This category is used when the clinician chooses not to specify the reason that the criteria are not met for a specific feeding or eating disorder, and includes presentations in which there is insufficient information to make a more specific diagnosis (e.g., in emergency room settings).

Definition[edit]

The DSM-5 defines UFED as any feeding or eating conditions that cause significant distress or impairment, but do not meet the full criteria for any of the other feeding and eating disorders. The disorder could be a less severe or less frequent version of a better-known disorder, or it could be a disorder that does not fit neatly into any existing category.

Symptoms[edit]

Symptoms of UFED can vary widely, as the category encompasses a range of conditions. However, common symptoms may include:

  • Persistent disturbance in eating or eating-related behavior that results in the altered consumption or absorption of food
  • The disturbance is not better explained by a lack of available food or by an associated culturally sanctioned practice
  • The eating disturbance does not occur exclusively during the course of anorexia nervosa or bulimia nervosa, and there is no evidence of recurrent episodes of binge eating.

Treatment[edit]

Treatment for UFED typically involves a combination of nutritional counseling, psychotherapy, and medication. The specific treatment plan will depend on the individual's specific symptoms and needs.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.